Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2007 2
2008 2
2009 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.
Raher MJ, Thibault HB, Buys ES, Kuruppu D, Shimizu N, Brownell AL, Blake SL, Rieusset J, Kaneki M, Derumeaux G, Picard MH, Bloch KD, Scherrer-Crosbie M. Raher MJ, et al. Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2495-502. doi: 10.1152/ajpheart.00139.2008. Epub 2008 Oct 31. Am J Physiol Heart Circ Physiol. 2008. PMID: 18978196 Free PMC article.
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV, Kohane DS, Bloch KD, Stasch JP, Volpato GP, Bellas E, Evgenov NV, Buys ES, Gnoth MJ, Graveline AR, Liu R, Hess DR, Langer R, Zapol WM. Evgenov OV, et al. Am J Respir Crit Care Med. 2007 Dec 1;176(11):1138-45. doi: 10.1164/rccm.200707-1121OC. Epub 2007 Sep 13. Am J Respir Crit Care Med. 2007. PMID: 17872487 Free PMC article.
Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
Vermeersch P, Buys E, Pokreisz P, Marsboom G, Ichinose F, Sips P, Pellens M, Gillijns H, Swinnen M, Graveline A, Collen D, Dewerchin M, Brouckaert P, Bloch KD, Janssens S. Vermeersch P, et al. Circulation. 2007 Aug 21;116(8):936-43. doi: 10.1161/CIRCULATIONAHA.106.677245. Epub 2007 Aug 6. Circulation. 2007. PMID: 17679618
Nitric oxide and cardiac remodeling.
Passeri J, Bloch KD. Passeri J, et al. Heart Fail Clin. 2005 Jul;1(2):275-86. doi: 10.1016/j.hfc.2005.04.002. Heart Fail Clin. 2005. PMID: 17386852 Review. No abstract available.
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD. Janssens S, et al. Circ Res. 2004 May 14;94(9):1256-62. doi: 10.1161/01.RES.0000126497.38281.23. Epub 2004 Mar 25. Circ Res. 2004. PMID: 15044322 Free article.